Geo-energy piles and walls have long been recognized as a promising way to reduce carbon dioxide emissions while providing renewable energy. However, enhancing the thermal performance of these structures has remained a signif-icant challenge. This thesis evaluated five different approaches to improving the thermal performance of geo-energy piles and walls, through a series of experiments using a fully instrumented testing rig. The first approach involved adding graphTHERM powder to concrete to double its thermal conductivity, boosting heat transfer efficiency by an impressive 50% to 66%. The second approach tested slag-based geopolymer concrete as a sustainable construc-tion material for geo-energy piles and walls, reducing CO2 emissions by 44.5% while improving thermal performance by 14% to 21%. The third approach in-volved testing thermally enhanced soils at the geo-energy structures/soil inter-face, resulting in an 81% improvement in heat transfer efficiency. The fourth approach utilized innovative phase change material (PCM) heat exchangers that increased heat transfer efficiency by 75% and 43% in heating and cooling operations, respectively. Finally, incorporated PCM-impregnated light weight aggregates at the interface of the structure soil, significantly increasing tem-perature difference and reducing thermal deformation of geo-energy struc-tures.Overall, these innovative approaches made a significant contribution to enhancing the thermal performance of geo-energy piles and walls. However, approaches four and five, which involve utilizing PCM heat exchangers and PCM-impregnated LWA's, respectively, showed extra benefits in dropping the thermal effect on soils and reducing the thermal damage on those structures. These techniques offer great promise for improving the thermal performance of geo-energy structures.

The main aim of the thesis was focused on hygrothermal simulation of critical details of two prefabricated wooden buildings - especially connections of the perimeter wall to monolithic foundations, respectively with waterproofing layer. The composition of the external walls of these selected buildings has quite different compositions and thus different potentials of drying integrated moisture from the components. Practical measurement of moisture weight-content was applied to the wooden bottom plate, which is in direct contact with the concrete slab structures. The influence of different design solutions on hygrothermal characteristics of the wooden plate was examined with regards to the risk of mould growth, analysis of mass loss due to the decay fungi and with the aim to estimate the durability of the studied details of prefabricated wooden houses. The subsequent research focused on the differences in physical and mechanical properties of natural spruce wood (Untreated, (-), A) and impregnated spruce (Treated, (+), B) using supercritical CO2 and its possible impact on wood protection for mould growth. Samples of identical Untreated and Treated spruce were collected in the laboratory and subjected to thermal and hygrothermal experiments. The comparison of the resulting values of the individual experiments is presented. Required values needed for numerical calculations were obtained from these experiments. In conclusion, the summary of founded comparison is presented. The mould growth analysis and its influence on the durability of wooden structures offer a view of the behaviour of the structures. Relevant findings and recommendations for the future praxis are mentioned.

Introdução: As Doenças lisossômicas (DLs) são condições genéticas, herdadas na sua maioria de forma autossômica recessiva, caracterizadas usualmente pela deficiência de enzimas lisossômicas específicas, envolvidas na síntese, degradação, armazenamento ou transporte de macromoléculas necessárias para o funcionamento normal do organismo. Nas situações mais típicas, o substrato não degradado acumula-se progressivamente nos lisossomos, com repercussões estruturais e funcionais, levando a sinais e sintomas característicos. Os pacientes apresentam um amplo espectro de manifestações clínicas, que podem incluir disfunção de órgãos, anormalidades esqueléticas, envolvimento neuronal, entre outras. O diagnóstico é usualmente obtido pela identificação da deficiência enzimática específica em leucócitos obtidos do sangue periférico, usualmente realizado em laboratórios de referência. O transporte da amostra pode ser um obstáculo quando o serviço requisitante está situado longe do centro de referência ou em outro país, situação em que a amostra de sangue pode chegar ao laboratório já sem condições de ser analisada. Objetivo: Este estudo teve como objetivo principal, tornar disponível um método mais simples, seguro e acessível que utiliza amostras de leucócitos impregnados em papel filtro (LIPF) como uma nova ferramenta para o diagnóstico bioquímico de pacientes com DLs. Métodos: O estudo envolveu amostras de pacientes com diagnóstico previamente confirmado de DLs (amostra de conveniência, por se tratarem de doenças raras, com incidências individuais ao redor de 1:100.000 recém-nascidos vivos). Foram incluídos no estudo os pacientes com diagnóstico já estabelecido de DLs selecionadas (MPS IVA, Doença de Krabbe, Doença de Gaucher e Doença de Pompe), independente do sexo e/ou idade, atendidos no Serviço de Genética Médica do HCPA, que concordaram em participar do estudo. O grupo de referência negativo foi constituído pelas amostras de 50 indivíduos hígidos, adultos, de ambos os sexos. Resultados: Os resultados obtidos nos ensaios enzimáticos de pacientes com MPS IVA, Doença de Krabbe, Doença de Gaucher e Doença de Pompe, indicaram que as enzimas analisadas em amostras de LIPF permitiram a identificação de todos os pacientes, com sensibilidade de 100%. Os testes de estabilidade realizados nas amostras de LIPF indicaram que as amostras, quando mantidas a 4ºC, se mostram estáveis por pelo menos 30 dias. Conclusões: Nas condições utilizadas, amostras de LIPF se mostraram adequadas para a identificação segura de pacientes com MPS tipo IVA, Doença de Krabbe, Doença de Gaucher e Doença de Pompe. As amostras de leucócitos secos em papel filtro são mais estáveis e seguras para o transporte, indicando que possa ser esta uma importante ferramenta para facilitar a identificação de pacientes com DLDs, especialmente daqueles que vivem em áreas que tem dificuldades para a remessa de amostras líquidas para serviços de referência. / Background: Lysosomal Disorders (LDs) are genetic conditions, mostly inherited in autosomal recessive fashion, usually characterized by a deficiency of specific lysosomal enzymes involved in the synthesis, degradation, storage or transportation of macromolecules necessary for normal functioning of the organism. Typically, the non-degraded substrate is progressively accumulated in lysosomes, with structural and functional repercussions, leading to characteristic signs and symptoms. Affected patients present a wide range of clinical manifestations, which may include organ dysfunction, skeletal anomalies, neuronal involvement, etc. The diagnosis is normally made through identification of the specific enzyme deficiency in white blood cells from a sample of peripheral blood, usually performed in reference laboratories. The transporting of a liquid sample can be a problem when the test orderer is located far from the reference center or in a foreign country, as often the blood sample arrives at the laboratory in poor condition and cannot be properly analyzed. Aim: The main aim of this study was to make available a new technique that is simpler, safer and more accessible, using leukocytes impregnated on filter paper (LIFP) as a new tool for the biochemical diagnosis of patients with LSDs. Methods: This study involved samples of patients with previously confirmed diagnosis of selected LSDs (a convenience sample, as these are rare diseases, with individual incidences around 1:100.000 live newborns). Patients with an established diagnosis of MPS IVA, Krabbe Disease, Gaucher’s disease and Pompe disease regardless of sex and/or age, cared for at the Genetics Service of HCPA and who agreed to participate were included in the study. The negative reference group comprised blood samples from 50 healthy adults of both genders. Results: The results obtained in the enzymatic assays of patients with MPS IVA, Krabbe Disease, Gaucher’s disease, and Pompe disease indicated that the analyzed enzymes in LIFP samples allowed the identification of all patients, with sensitivity of 100%. The stability tests performed in LIFP samples indicated that samples, when maintained at 4ºC, were stable for at least 30 days. Conclusions: In the conditions used, LIFP samples were shown to be adequate for a reliable identification of patients with MPS IVA, Krabbe Disease, Gaucher’s disease, and Pompe disease. Blood samples on filter paper are more stable and reliable for transportation, indicating that this may be an important tool to facilitate the identification of patients with LSDs, particularly those living in areas with difficulties for the shipment of liquid samples to reference cervices.

Le paludisme est l’une des maladies infectieuses la plus fréquente au monde avec 40% de la population mondiale exposée. En dépit des stratégies actuelles de lutte notamment la prise en charge rapide des cas, l’utilisation de matériaux imprégnés et la pulvérisation intra domiciliaire d’insecticide, le paludisme reste une des premières causes de morbidité et de mortalité notamment en Afrique subsaharienne. Cette partie du monde totalise à elle seule plus de 90% des cas de décès par paludisme dont 88% chez les enfants de moins de moins de 5 ans. En absence de vaccin utilisable en santé publique, il y a donc un besoin urgent de trouver une stratégie efficiente et simple de contrôle du paludisme. Le traitement préventif intermittent (TPI) définie comme l’administration d’un antipaludique à dose curative à des intervalles de temps prédéfinis réduit l’incidence du paludisme et apparaît aujourd’hui comme une des stratégies les plus prometteuses. Cette stratégie couplée au Programme Elargi de Vaccination (PEV) chez les enfants de moins de 1 an réduit l’incidence du paludisme de 30%. Des résultats plus importants sont obtenus chez les enfants de 0 à 5 ans voire de 0 à 10 ans lorsque la stratégie est appliquée en ciblant la saison de transmission. Nos travaux de recherche au Mali ont porté sur :- l’impact de la mise en œuvre du TPI couplé à la vaccination du PEV (TPin) sur i) la résistance P. falciparum à la Sulfadoxine pyrimethamine (SP), ii) la couverture des vaccins du PEV, iii) le taux de mortalité des enfants âgés de 4 à 18 mois.- l’efficacité du TPI chez les enfants ciblant la saison de transmission (TPIe) dans un contexte de faible et de forte couverture en des Moustiquaires Imprégnés d’Insecticides (MII). Nos résultats ont montré qu’après une année de mise en œuvre à l’échelle du district sanitaire, le TPIn a entrainé une augmentation de la couverture des vaccins du PEV. Cette couverture était de 53% en zone de non-intervention contre 69.5% en zone d’intervention (p<0.01). Il y a eu une réduction de la mortalité globale de 27% (RR= 0,73, IC95% : 0,55-0,97, p=0,029) chez les enfants âgés de 4 à 18 mois. Les fréquences des marqueurs moléculaires de la résistance de P. falciparum à SP en début et en fin la mise en œuvre et entre la zone d’intervention et la zone de non –intervention après une année de mise en œuvre étaient similaires. Deux doses de SP données en TPI à 8 semaines d’ intervalle durant la saison de transmission réduit le taux d’incidence du paludisme pendant la saison de transmission de 69,4% chez les enfants de moins de 5 ans et de 63,4% chez les enfants de 5-10 ans dans un contexte de très faible utilisation de MII (<5%). Dans une autre étude que nous avons menée, le TPI avec SP + Amodiaquine (AQ) donné en 3 occasions à un mois d’ intervalle pendant la saison de transmission a réduit le taux d’ incidence du paludisme clinique non compliqué de 82% (IC à 95%: 78%– 85%; P<0.001) et les formes graves de paludisme de 87% (IC à 95% 42% – 99%, P=0.001) chez les enfants âgés de 3 à 59 mois en dépit un taux d’utilisation des MII de plus de 99%. Nous n’avons pas documenté d’événement indésirable grave lié à l’utilisation de la SP ou de la SP + AQ en TPI durant ces deux études. Nos résultats étayent la recommandation du TPI, ciblant la saison de transmission ou couplée au PEV, pour la lutte antipaludique chez les enfants. / Malaria is one of the most common infectious diseases in the world and 40% of the world population is exposed to malaria. Despite the current control strategies such as rapid diagnosis and treatment of disease cases, use of insecticide impregnated materials and indoor residuals spraying with insecticides, malaria remained a main cause of morbidity and mortality particularly in sub Saharan Africa. More than 90% of the deaths due to malaria occurred in this region and 88% of these deaths occurred in children aged less than 5 years of age. In absence of vaccine that can be used in public health, there is an urgent need for a simple and efficient control strategy. Malaria intermittent preventive treatment (IPT) defined as the administration of curative dose of anti-malarial drug at predefined time intervals, appears as one of the most promising strategies. Given through the Expanded Program of Immunization (EPI), the strategy reduced the incidence of malaria by 30%. More drastic reductions were obtained in children aged 0-5 years and even 0-10 years when the malaria transmission season was targeted for the administration of the strategy. Our research work in Mali has assessed the following:- The impact of implementation of IPT administrated through EPI (IPTi) on: i) the resistance of P. falciparum to Sulfadoxine pyrimethamine (SP); ii) EPI vaccine coverage, and iii) mortality of children of 4-18 months of age. - The efficacy of IPT in children targeting the malaria transmission season (IPTe) in a context of low and high coverage of insecticide impregnated nets (ITN).We have found that the implementation of IPTi at the district level has resulted in an augmentation of the EPI vaccine coverage. The EPI vaccine coverage was 53% in the non-intervention zone compared to 69.5% in the intervention zone (p<0,01). There was a reduction in all cause mortality of 27% (RR= 0.73, 95% CI : 0.55-0.97, p=0.029) in children aged 4-18 months. The frequencies of molecular markers of the resistance of P. falciparum to SP were similar at the beginning and the end of the one year implementation period and between the intervention and non-intervention zones.Two doses of SP given at 8 weeks interval during the transmission season, reduced the incidence of malaria episodes during the transmission season by 69.4% in children aged less than 5 years and by 63.4% in children aged 5-10 years in a context of very low ITN use (<5%). In another study that we have conducted, IPT with SP + Amodiaquine (AQ) given at three occasions at one month interval during the transmission season reduced the incidence rate of clinical malaria by 82% (95% CI: 78%– 85%; P<0.001), and the incidence of severe and complicated malaria by 87% (95% IC 42% – 99%, P=0.001) in children aged 3 to 59 months of age despite an ITN use of greater than 99%.There was no serious adverse event related to the use of SP or SP+AQ in IPT during the two studies. Our results support the recommendation of IPT targeting the transmission season and IPT given through the EPI for malaria control in children.

Power and Generator Transformers are important and expensive elements of a power system. Inadvertent failure of Power Transformers would cause long interruption in power supply with consequent loss of reliability and revenue to the supply utilities. The mineral oil impregnated paper, OIP, is an insulation of choice in large power transformers in view of its excellent dielectric and other properties, besides being relatively inexpensive. During the normal working regime of the transformer, the insulation thereof is subjected to various stresses, the more important among them are, electrical, thermal, mechanical and chemical. Each of these stresses, appearing singly, or in combination, would lead to a time variant deterioration in the properties of insulation, called Ageing. This normal and inevitable process of degradation in the several essential properties of the insulation is irreversible, is a non-Markov physico-chemical reaction kinetic process. The speed or the rapidity of insulation deterioration is a very strong function of the magnitude of the stresses and the duration over which they acted. This is further compounded, if the stresses are in synergy. During the processes of ageing, some, or all the vital properties undergo subtle changes, more often, not in step with the duration of time over which the damage has been accumulated. Often, these changes are non monotonic, thus presenting a random or a chaotic picture and understanding the processes leading to eventual failure becomes difficult. But, there is some order in this chaos, in that, the time average of the changes over short intervals of time, seems to indicate some degree of predictability. The status of insulation at any given point in time is assessed by measuring such of those properties as are sensitive to the amount of ageing and comparing it with earlier measurements. This procedure, called the Diagnostic or nondestructive Testing, has been in vogue for some time now. Of the many parameters used as sensitive indices of the dynamics of insulation degradation, temporal changes in temperatures at different locations in the body of the transformer, more precisely, the winding hot spots (HST) and top oil temperature (TOT) are believed to give a fairly accurate indication of the rate of degradation. Further, an accurate estimation of the temperatures would enable to determine the loading limit (loadability) of power transformer. To estimate the temperature rise reasonably accurately, one has to resort to classical mathematical techniques involving formulation and solution of boundary value problem of heat conduction under carefully prescribed boundary conditions. Several complications are encountered in the development of the governing equations for the emergent heat transfer problems. The more important among them are, the inhomogeneous composition of the insulation structure and of the conductor, divergent flow patterns of the oil phase and inordinately varying thermal properties of conductor and insulation. Validation and reconfirmation of the findings of the thermal models can be made using state of the art methods, such as, Artificial Intelligence (AI) techniques, Artificial Neural Network (ANN) and Genetic Algorithm (GA). Over the years, different criteria have been prescribed for the prediction of terminal or end of life (EOL) of equipment from the standpoint of its insulation. But, thus far, no straightforward and unequivocal criterion is forth coming. Calculation of elapsed life in line with the existing methodology, given by IEEE, IEC, introduces unacceptable degrees of uncertainty. It is needless to say that, any conformal procedure proposed in the accurate prediction of EOL, has to be based on a technically feasible and economically viable consideration. A systematic study for understanding the dynamical nature of ageing in transformers in actual service is precluded for reasons very well known. Laboratory experiments on prototypes or pro-rated units fabricated based on similarity studies, are performed under controlled conditions and at accelerated stress levels to reduce experimental time. The results thereof can then be judiciously extrapolated to normal operating conditions and for full size equipment. The terms of reference of the present work are as follows; 1. Computation of TOT and HST Theoretical model based on Boundary Value Problem of Heat Conduction Application of AI Techniques 2. Experimental Investigation for estimating the Elapsed Life of transformers Based on the experimental investigation a semi-empirical expression has been developed to estimate the loss of life of power and station transformer by analyzing gas content and furfural dissolved in oil without performing off-line and destructive tests.

Die bei Textilbetonen überwiegend zum Einsatz kommenden Bewehrungen aus AR-Glas weisen infolge der Glaskorrosion einen signifikanten Tragfähigkeitsverlust auf. Im Rahmen des Teilprojektes D5 des SFB 532 wurden die Faktoren, die die Dauerhaftigkeit des Werkstoffes beeinflussen, evaluiert und in einen Modellansatz umgesetzt. Anhand dieser Untersuchungen konnten Möglichkeiten zur Reduktion des langfristigen Festigkeitsverlustes aufgezeigt werden. Eine dieser Möglichkeiten ist die Polymermodifikation des Betons, die im Wesentlichen einen Einfluss auf den Wassertransport innerhalb des Betonquerschnitts hat. Im Rahmen des Teilprojektes B4 des SFB 532 wurden polymermodifizierte Betone entwickelt und hinsichtlich ihres Wasseraufnahmeverhaltens untersucht. Im Anschluss wird die Wirkungsweise polymermodifizierter Betone hinsichtlich der Einflüsse auf die Dauerhaftigkeit von TRC beschrieben.

Pour faire face à l’augmentation des émissions de CO2 dans l’atmosphère à cause de la production électrique dans des centrales à charbon, le captage en post-combustion au moyen d’un procédé VSA est une solution envisageable. Les adsorbants utilisés dans notre étude sont la TEPA imprégnée sur SiO2, les oxydes de terre rare et le MOF (Metal Organic Frameworks) SIM-1. Pour chaque adsorbant, une étude du perçage puis de la régénération a été effectuée à partir d’une alimentation composée de 15%vol de CO2 et de N2. De ces essais, les conditions opératoires des cycles VSA ont été établies (durées des phases courtes, pas de circulation de purge). En cycle, les performances sont comparées à celle du procédé d’absorption avec la monoéthénolamine. La pureté du désorbat varie de 89,2%vol à 97,2%vol selon les adsorbants et les conditions opératoires. Elle est inférieure à celle du procédé d’absorption (99%vol) mais est correcte pour le transport et le stockage. Le taux de captage évolue de 87,2% à 94,9% (absorption : 98%). La consommation énergétique est inférieure à celle du procédé avec la MEA (de 1,53 à 3,45 MJ.kgCO2 1 pour notre procédé et 3,7 MJ.kgCO2¬1 pour l’absorption) Enfin la productivité est du même ordre de grandeur que celle d’autres procédés VSA de la littérature. Avec le modèle numérique, une étude locale de l’adsorbeur a été menée. Puis grâce à une étude paramétrique, des conditions optimales en cycle ont été déterminées. Les résultats obtenus ont permis de mettre en évidence des performances comparables avec les autres procédés VSA de la littérature. De plus, notre procédé est beaucoup moins énergivore que le procédé d’absorption mais la pureté du désorbat et le taux de captage en CO2 restent inférieurs. / To deal with the CO2 emissions increase in the atmosphere due to electricity production, CO2 post-combustion capture by VSA process is a promising solution. The adsorbents used in this study are impregnated TEPA on SiO2, lanthanide oxides and the MOF (Metal Organic Frameworks) SIM-1. For each adsorbent, a study of breakthrough and regeneration was carried out from a feed composed of 15%vol CO2 and N2. From these experiments, the cyclic operating conditions of VSA have been established (short duration phases, no purge). Cyclic performances are compared to that of the absorption process with monoethenolamine. The desorbate purity varies from 89.2% to 97.2%vol according to adsorbent and operating conditions. It is less than that obtained with absorption process (99%vol) but it is correct for transport and storage. The recovery varies from 87.2% to 94.2% (absorption: 98%). The energy consumption is less than that the process with the MEA (from 1.53 to 3.45 MJ.kgCO2 1 for our process and 3.7 MJ.kgCO2 1 for absorption). . Finally, the productivity is of the same order of magnitude as that of other VSA processes from literature. With the numerical model, a local study of the adsorber was carried out. Afterwards, through a parametric study, cycle optimal conditions were determined. The cycle results highlighted comparable performances with the other VSA processes from literature. Moreover, our process needs less energy than absorption process but the desorbate purity and CO2 recovery remain lower.

Introdução: As Doenças lisossômicas (DLs) são condições genéticas, herdadas na sua maioria de forma autossômica recessiva, caracterizadas usualmente pela deficiência de enzimas lisossômicas específicas, envolvidas na síntese, degradação, armazenamento ou transporte de macromoléculas necessárias para o funcionamento normal do organismo. Nas situações mais típicas, o substrato não degradado acumula-se progressivamente nos lisossomos, com repercussões estruturais e funcionais, levando a sinais e sintomas característicos. Os pacientes apresentam um amplo espectro de manifestações clínicas, que podem incluir disfunção de órgãos, anormalidades esqueléticas, envolvimento neuronal, entre outras. O diagnóstico é usualmente obtido pela identificação da deficiência enzimática específica em leucócitos obtidos do sangue periférico, usualmente realizado em laboratórios de referência. O transporte da amostra pode ser um obstáculo quando o serviço requisitante está situado longe do centro de referência ou em outro país, situação em que a amostra de sangue pode chegar ao laboratório já sem condições de ser analisada. Objetivo: Este estudo teve como objetivo principal, tornar disponível um método mais simples, seguro e acessível que utiliza amostras de leucócitos impregnados em papel filtro (LIPF) como uma nova ferramenta para o diagnóstico bioquímico de pacientes com DLs. Métodos: O estudo envolveu amostras de pacientes com diagnóstico previamente confirmado de DLs (amostra de conveniência, por se tratarem de doenças raras, com incidências individuais ao redor de 1:100.000 recém-nascidos vivos). Foram incluídos no estudo os pacientes com diagnóstico já estabelecido de DLs selecionadas (MPS IVA, Doença de Krabbe, Doença de Gaucher e Doença de Pompe), independente do sexo e/ou idade, atendidos no Serviço de Genética Médica do HCPA, que concordaram em participar do estudo. O grupo de referência negativo foi constituído pelas amostras de 50 indivíduos hígidos, adultos, de ambos os sexos. Resultados: Os resultados obtidos nos ensaios enzimáticos de pacientes com MPS IVA, Doença de Krabbe, Doença de Gaucher e Doença de Pompe, indicaram que as enzimas analisadas em amostras de LIPF permitiram a identificação de todos os pacientes, com sensibilidade de 100%. Os testes de estabilidade realizados nas amostras de LIPF indicaram que as amostras, quando mantidas a 4ºC, se mostram estáveis por pelo menos 30 dias. Conclusões: Nas condições utilizadas, amostras de LIPF se mostraram adequadas para a identificação segura de pacientes com MPS tipo IVA, Doença de Krabbe, Doença de Gaucher e Doença de Pompe. As amostras de leucócitos secos em papel filtro são mais estáveis e seguras para o transporte, indicando que possa ser esta uma importante ferramenta para facilitar a identificação de pacientes com DLDs, especialmente daqueles que vivem em áreas que tem dificuldades para a remessa de amostras líquidas para serviços de referência. / Background: Lysosomal Disorders (LDs) are genetic conditions, mostly inherited in autosomal recessive fashion, usually characterized by a deficiency of specific lysosomal enzymes involved in the synthesis, degradation, storage or transportation of macromolecules necessary for normal functioning of the organism. Typically, the non-degraded substrate is progressively accumulated in lysosomes, with structural and functional repercussions, leading to characteristic signs and symptoms. Affected patients present a wide range of clinical manifestations, which may include organ dysfunction, skeletal anomalies, neuronal involvement, etc. The diagnosis is normally made through identification of the specific enzyme deficiency in white blood cells from a sample of peripheral blood, usually performed in reference laboratories. The transporting of a liquid sample can be a problem when the test orderer is located far from the reference center or in a foreign country, as often the blood sample arrives at the laboratory in poor condition and cannot be properly analyzed. Aim: The main aim of this study was to make available a new technique that is simpler, safer and more accessible, using leukocytes impregnated on filter paper (LIFP) as a new tool for the biochemical diagnosis of patients with LSDs. Methods: This study involved samples of patients with previously confirmed diagnosis of selected LSDs (a convenience sample, as these are rare diseases, with individual incidences around 1:100.000 live newborns). Patients with an established diagnosis of MPS IVA, Krabbe Disease, Gaucher’s disease and Pompe disease regardless of sex and/or age, cared for at the Genetics Service of HCPA and who agreed to participate were included in the study. The negative reference group comprised blood samples from 50 healthy adults of both genders. Results: The results obtained in the enzymatic assays of patients with MPS IVA, Krabbe Disease, Gaucher’s disease, and Pompe disease indicated that the analyzed enzymes in LIFP samples allowed the identification of all patients, with sensitivity of 100%. The stability tests performed in LIFP samples indicated that samples, when maintained at 4ºC, were stable for at least 30 days. Conclusions: In the conditions used, LIFP samples were shown to be adequate for a reliable identification of patients with MPS IVA, Krabbe Disease, Gaucher’s disease, and Pompe disease. Blood samples on filter paper are more stable and reliable for transportation, indicating that this may be an important tool to facilitate the identification of patients with LSDs, particularly those living in areas with difficulties for the shipment of liquid samples to reference cervices.

Introdução: As Doenças lisossômicas (DLs) são condições genéticas, herdadas na sua maioria de forma autossômica recessiva, caracterizadas usualmente pela deficiência de enzimas lisossômicas específicas, envolvidas na síntese, degradação, armazenamento ou transporte de macromoléculas necessárias para o funcionamento normal do organismo. Nas situações mais típicas, o substrato não degradado acumula-se progressivamente nos lisossomos, com repercussões estruturais e funcionais, levando a sinais e sintomas característicos. Os pacientes apresentam um amplo espectro de manifestações clínicas, que podem incluir disfunção de órgãos, anormalidades esqueléticas, envolvimento neuronal, entre outras. O diagnóstico é usualmente obtido pela identificação da deficiência enzimática específica em leucócitos obtidos do sangue periférico, usualmente realizado em laboratórios de referência. O transporte da amostra pode ser um obstáculo quando o serviço requisitante está situado longe do centro de referência ou em outro país, situação em que a amostra de sangue pode chegar ao laboratório já sem condições de ser analisada. Objetivo: Este estudo teve como objetivo principal, tornar disponível um método mais simples, seguro e acessível que utiliza amostras de leucócitos impregnados em papel filtro (LIPF) como uma nova ferramenta para o diagnóstico bioquímico de pacientes com DLs. Métodos: O estudo envolveu amostras de pacientes com diagnóstico previamente confirmado de DLs (amostra de conveniência, por se tratarem de doenças raras, com incidências individuais ao redor de 1:100.000 recém-nascidos vivos). Foram incluídos no estudo os pacientes com diagnóstico já estabelecido de DLs selecionadas (MPS IVA, Doença de Krabbe, Doença de Gaucher e Doença de Pompe), independente do sexo e/ou idade, atendidos no Serviço de Genética Médica do HCPA, que concordaram em participar do estudo. O grupo de referência negativo foi constituído pelas amostras de 50 indivíduos hígidos, adultos, de ambos os sexos. Resultados: Os resultados obtidos nos ensaios enzimáticos de pacientes com MPS IVA, Doença de Krabbe, Doença de Gaucher e Doença de Pompe, indicaram que as enzimas analisadas em amostras de LIPF permitiram a identificação de todos os pacientes, com sensibilidade de 100%. Os testes de estabilidade realizados nas amostras de LIPF indicaram que as amostras, quando mantidas a 4ºC, se mostram estáveis por pelo menos 30 dias. Conclusões: Nas condições utilizadas, amostras de LIPF se mostraram adequadas para a identificação segura de pacientes com MPS tipo IVA, Doença de Krabbe, Doença de Gaucher e Doença de Pompe. As amostras de leucócitos secos em papel filtro são mais estáveis e seguras para o transporte, indicando que possa ser esta uma importante ferramenta para facilitar a identificação de pacientes com DLDs, especialmente daqueles que vivem em áreas que tem dificuldades para a remessa de amostras líquidas para serviços de referência. / Background: Lysosomal Disorders (LDs) are genetic conditions, mostly inherited in autosomal recessive fashion, usually characterized by a deficiency of specific lysosomal enzymes involved in the synthesis, degradation, storage or transportation of macromolecules necessary for normal functioning of the organism. Typically, the non-degraded substrate is progressively accumulated in lysosomes, with structural and functional repercussions, leading to characteristic signs and symptoms. Affected patients present a wide range of clinical manifestations, which may include organ dysfunction, skeletal anomalies, neuronal involvement, etc. The diagnosis is normally made through identification of the specific enzyme deficiency in white blood cells from a sample of peripheral blood, usually performed in reference laboratories. The transporting of a liquid sample can be a problem when the test orderer is located far from the reference center or in a foreign country, as often the blood sample arrives at the laboratory in poor condition and cannot be properly analyzed. Aim: The main aim of this study was to make available a new technique that is simpler, safer and more accessible, using leukocytes impregnated on filter paper (LIFP) as a new tool for the biochemical diagnosis of patients with LSDs. Methods: This study involved samples of patients with previously confirmed diagnosis of selected LSDs (a convenience sample, as these are rare diseases, with individual incidences around 1:100.000 live newborns). Patients with an established diagnosis of MPS IVA, Krabbe Disease, Gaucher’s disease and Pompe disease regardless of sex and/or age, cared for at the Genetics Service of HCPA and who agreed to participate were included in the study. The negative reference group comprised blood samples from 50 healthy adults of both genders. Results: The results obtained in the enzymatic assays of patients with MPS IVA, Krabbe Disease, Gaucher’s disease, and Pompe disease indicated that the analyzed enzymes in LIFP samples allowed the identification of all patients, with sensitivity of 100%. The stability tests performed in LIFP samples indicated that samples, when maintained at 4ºC, were stable for at least 30 days. Conclusions: In the conditions used, LIFP samples were shown to be adequate for a reliable identification of patients with MPS IVA, Krabbe Disease, Gaucher’s disease, and Pompe disease. Blood samples on filter paper are more stable and reliable for transportation, indicating that this may be an important tool to facilitate the identification of patients with LSDs, particularly those living in areas with difficulties for the shipment of liquid samples to reference cervices.

Die bei Textilbetonen überwiegend zum Einsatz kommenden Bewehrungen aus AR-Glas weisen infolge der Glaskorrosion einen signifikanten Tragfähigkeitsverlust auf. Im Rahmen des Teilprojektes D5 des SFB 532 wurden die Faktoren, die die Dauerhaftigkeit des Werkstoffes beeinflussen, evaluiert und in einen Modellansatz umgesetzt. Anhand dieser Untersuchungen konnten Möglichkeiten zur Reduktion des langfristigen Festigkeitsverlustes aufgezeigt werden. Eine dieser Möglichkeiten ist die Polymermodifikation des Betons, die im Wesentlichen einen Einfluss auf den Wassertransport innerhalb des Betonquerschnitts hat. Im Rahmen des Teilprojektes B4 des SFB 532 wurden polymermodifizierte Betone entwickelt und hinsichtlich ihres Wasseraufnahmeverhaltens untersucht. Im Anschluss wird die Wirkungsweise polymermodifizierter Betone hinsichtlich der Einflüsse auf die Dauerhaftigkeit von TRC beschrieben.